What are the considerations for methyldopa use in hypertensive patients with peripheral artery disease and how does it affect vascular health?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Methyldopa, used for hypertension, can reduce blood pressure but might not improve and could potentially worsen blood flow in peripheral artery disease (PAD) patients due to its mechanism of reducing peripheral vascular resistance.